|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sathornsumetee S, Rich JN and Reardon DA:
Diagnosis and treatment of high-grade astrocytoma. Neurol Clin.
251111–1139. (x)2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Filippini G, Falcone C, Boiardi A, Broggi
G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L,
Finocchiaro G, et al: Prognostic factors for survival in 676
consecutive patients with newly diagnosed primary glioblastoma.
Neuro Oncol. 10:79–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barnes MN, Deshane JS, Rosenfeld M, Siegal
GP, Curiel DT and Alvarez RD: Gene therapy and ovarian cancer: A
review. Obstet Gynecol. 89:145–155. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson BG, Wang X, Shen X, McKenna ES,
Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH and
Roberts CW: Epigenetic antagonism between polycomb and SWI/SNF
complexes during oncogenic transformation. Cancer Cell. 18:316–328.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su Y, Deng B and Xi R: Polycomb group
genes in stem cell self-renewal: A double-edged sword. Epigenetics.
6:16–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morey L and Helin K: Polycomb group
protein-mediated repression of transcription. Trends Biochem Sci.
35:323–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sauvageau M and Sauvageau G: Polycomb
group proteins: Multi-faceted regulators of somatic stem cells and
cancer. Cell Stem Cell. 7:299–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prezioso C and Orlando V: Polycomb
proteins in mammalian cell differentiation and plasticity. FEBS
Lett. 585:2067–2077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pasini D, Bracken AP and Helin K: Polycomb
group proteins in cell cycle progression and cancer. Cell Cycle.
3:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacobs JJ and van Lohuizen M: Polycomb
repression: From cellular memory to cellular proliferation and
cancer. Biochim Biophys Acta. 1602:151–161. 2002.PubMed/NCBI
|
|
12
|
Chang CJ and Hung MC: The role of EZH2 in
tumour progression. Br J Cancer. 106:243–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nunes M, Blanc I, Maes J, Fellous M,
Robert B and McElreavey K: NSPc1, a novel mammalian Polycomb gene,
is expressed in neural crest-derived structures of the peripheral
nervous system. Mech Dev. 102:219–222. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Fan R, Sun M, Jiang T and Gong Y:
Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19
embryonal carcinoma cells via directly activating Oct4. Biochem
Biophys Res Commun. 440:527–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pritsker M, Ford NR, Jenq HT and Lemischka
IR: Genomewide gain-of-function genetic screen identifies
functionally active genes in mouse embryonic stem cells. Proc Natl
Acad Sci USA. 103:6946–6951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan Y, Zhao W, Huang Y, Tong H, Xia Y,
Jiang Q and Qin J: Loss of polycomb group protein Pcgf1 severely
compromises proper differentiation of embryonic stem cells. Sci
Rep. 7:462762017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong Y, Yue J, Wu X, Wang X, Wen J, Lu L,
Peng X, Qiang B and Yuan J: NSPc1 is a cell growth regulator that
acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE
element. Nucleic Acids Res. 34:6158–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu PS, Xia QS, Wu F, Li DK, Qi YJ, Hu Y,
Wei ZZ, Li SS, Tian NY, Wei QF, et al: NSPc1 promotes cancer stem
cell self-renewal by repressing the synthesis of all-trans retinoic
acid via targeting RDH16 in malignant glioma. Oncogene.
36:4706–4718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Liu N, Wang JP, Wang YQ, Yu XL,
Wang ZB, Cheng XC and Zou Q: Regulatory long non-coding RNA and its
functions. J Physiol Biochem. 68:611–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okazaki Y, Furuno M, Kasukawa T, Adachi J,
Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15(INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu Q, Ren S, Lu M, Zhang Y, Zhu D, Zhang X
and Li T: Computational prediction of associations between long
non-coding RNAs and proteins. BMC Genomics. 14:6512013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu X, Gong Y, Yue J, Qiang B, Yuan J and
Peng X: Cooperation between EZH2, NSPc1-mediated histone H2A
ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res.
36:3590–3599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiang J, Guo S, Jiang S, Xu Y, Li J, Li L
and Xiang J: Silencing of long non-coding RNA MALAT1 promotes
apoptosis of glioma cells. J Korean Med Sci. 31:688–694. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shahryari A, Rafiee MR, Fouani Y, Oliae
NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two
novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are
coupregulated with SOX2 and OCT4 in esophageal squamous cell
carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang D, Ding L, Li Y, Ren J, Shi G, Wang
Y, Zhao S, Ni Y and Hou Y: Midkine derived from cancer-associated
fibroblasts promotes cisplatin-resistance via up-regulation of the
expression of lncRNA ANRIL in tumour cells. Sci Rep. 7:162312017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rolle K: miRNA multiplayers in glioma.
From bench to bedside. Acta Biochim Pol. 62:353–365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development.
ScientificWorldJournal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ling GQ, Liu YJ, Ke YQ, Chen L, Jiang XD,
Jiang CL and Ye W: All-trans retinoic acid impairs the vasculogenic
mimicry formation ability of U87 stem-like cells through promoting
differentiation. Mol Med Rep. 12:165–172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiao F, Hu H, Han T, Yuan C and Wang L,
Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem
cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci.
16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shahryari A, Rafiee MR, Fouani Y, Oliae
NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two
novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are
coupregulated with SOX2 and OCT4 in esophageal squamous cell
carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W and Chen JF: Long noncoding RNA
ANRIL indicates a poor prognosis of gastric cancer and promotes
tumor growth by epigenetically silencing of miR-99a/miR-449a.
Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
